Literature DB >> 25289

Alpah-adrenergic receptor modulation of beta-adrenergic, adenosine and prostaglandin E1 increased adenosine 3':5'-cyclic monophosphate levels in primary cultures of glia.

K D McCarthy, J de Vellis.   

Abstract

Beta-adrenergic agonists, adenosine and prostaglandin E1 increased the level of adenosine 3':5'-monophosphate (cAMP) in glial cultures prepared from rat cerebral cortical tissue. In addition to these physiological effectors, cholera toxin also increased cAMP levels in these cultures. The accumulation of cAMP in response to each of these agen-s, including cholera toxin, was partially blocked (50--80%) by simultaneous alpha-adrenergic receptor stimulation. Basal levels of cAMP were not affected by alpha-adrenergic agonists. These results indicate that in glia, alpha-adrenergic receptors may serve to modulate the level of cAMP which normally accumulates in response to a number of neurohumoral substances. The modulatory effect of alpha-adrenergic agents does not appear to reduce cAMP accumulation by activating phosphodiesterase since the effect was not blocked by a potent inhibitor of this enzymemthe results suggest that the modulatory effect of alpha-adrenergic receptor activation results from an interaction which takes place at some point in between adenylate cyclase-associated-membrane receptors and the enzymatic degradation of cAMP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25289

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  33 in total

1.  In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.

Authors:  S Beushausen; S Narindrasorasak; B D Sanwal; S Dales
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms.

Authors:  E M Frohman; B Vayuvegula; S Gupta; S van den Noort
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Chronic encephalopathies induced by mercury or lead: aspects of underlying cellular and molecular mechanisms.

Authors:  L Rönnbäck; E Hansson
Journal:  Br J Ind Med       Date:  1992-04

4.  Freeze-etching and vapor matrix deposition for ToF-SIMS imaging of single cells.

Authors:  Paul D Piehowski; Michael E Kurczy; David Willingham; Shawn Parry; Michael L Heien; Nicholas Winograd; Andrew G Ewing
Journal:  Langmuir       Date:  2008-06-21       Impact factor: 3.882

5.  Neuronal modulation of calcium channel activity in cultured rat astrocytes.

Authors:  V Corvalan; R Cole; J de Vellis; S Hagiwara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.

Authors:  A Stiene-Martin; K F Hauser
Journal:  J Neurosci Res       Date:  1991-08       Impact factor: 4.164

7.  Clonidine inhibits the isoproterenol-induced desensitization of the beta noradrenergic activated adenylate cyclase system in astrocytes.

Authors:  W J Northam; P L Mobley
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Expression of preproenkephalin mRNA by cultured astrocytes and neurons.

Authors:  M H Vilijn; P J Vaysse; R S Zukin; J A Kessler
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 9.  What is the role of astrocyte calcium in neurophysiology?

Authors:  Cendra Agulhon; Jeremy Petravicz; Allison B McMullen; Elizabeth J Sweger; Suzanne K Minton; Sarah R Taves; Kristen B Casper; Todd A Fiacco; Ken D McCarthy
Journal:  Neuron       Date:  2008-09-25       Impact factor: 17.173

10.  Monoamine regulation of adenosine 3',5'-monophosphate in homogeneous neuronal cultures from chick brain hemispheres.

Authors:  J Ciesielski-Treska; G Ulrich
Journal:  Neurochem Res       Date:  1980-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.